SEC Form 4 · accession 0000899243-18-001111
APPLIED GENETIC TECHNOLOGIES CORP · AGTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Matthew Feinsod
Officer — Interim Chief Medical Officer
Period of report
Jan 11, 2018
Accepted (ET)
Jan 16, 2018 · 8:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001273636
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 11, 2018 | A | 2,000 | $0.00 | A | 29,648 | D | |
| Common Stock | Jan 11, 2018 | F | 855 | $4.30 | D | 28,793 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The common stock vested immediately upon grant.